Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Comparison of Endoplasmic Reticulum Stress Messenger Ribonucleic Acid Expression Between Chronic Otitis Media With and Without Cholesteatoma

View through CrossRef
BACKGROUND: We evaluated and compared the role of endoplasmic reticulum stress in chronic otitis media with cholesteatoma and chronic otitis media without cholesteatoma. METHODS: The messenger ribonucleic acid expression of endoplasmic reticulum stress was measured and compared between chronic otitis media with cholesteatoma and chronic otitis media without cholesteatoma according to the presence or absence of bacteria, type of hearing loss, ossicle destruction, and facial canal dehiscence. RESULTS: The expression of immunoglobulin heavy chain-binding protein messenger ribonucleic acid was higher in the chronic otitis media without cholesteatoma group than in the chronic otitis media with cholesteatoma group, and Protein kinase RNA (PKR)-like endoplasmic reticulum kinase and activating transcription factor 6 messenger ribonucleic acid expression were higher in the chronic otitis media with cholesteatoma group than in the chronic otitis media without cholesteatoma group. CONCLUSION: Endoplasmic reticulum stress messenger ribonucleic acids were expressed in both chronic otitis media with cholesteatoma and chronic otitis media without cholesteatoma. The levels of expression of endoplasmic reticulum stress messenger ribonucleic acids differed according to clinical features, suggesting that different endoplasmic reticulum stress pathways are involved in the pathophysiology of different types of chronic otitis media. Cite this article as: Woong Kang D, Jun Kim Y, Soo Kim S, et al. Comparison of endoplasmic reticulum stress messenger ribonucleic acid expression between chronic otitis media with and without cholesteatoma. J Int Adv Otol. 2023;19(4):271-276.
Title: Comparison of Endoplasmic Reticulum Stress Messenger Ribonucleic Acid Expression Between Chronic Otitis Media With and Without Cholesteatoma
Description:
BACKGROUND: We evaluated and compared the role of endoplasmic reticulum stress in chronic otitis media with cholesteatoma and chronic otitis media without cholesteatoma.
METHODS: The messenger ribonucleic acid expression of endoplasmic reticulum stress was measured and compared between chronic otitis media with cholesteatoma and chronic otitis media without cholesteatoma according to the presence or absence of bacteria, type of hearing loss, ossicle destruction, and facial canal dehiscence.
RESULTS: The expression of immunoglobulin heavy chain-binding protein messenger ribonucleic acid was higher in the chronic otitis media without cholesteatoma group than in the chronic otitis media with cholesteatoma group, and Protein kinase RNA (PKR)-like endoplasmic reticulum kinase and activating transcription factor 6 messenger ribonucleic acid expression were higher in the chronic otitis media with cholesteatoma group than in the chronic otitis media without cholesteatoma group.
CONCLUSION: Endoplasmic reticulum stress messenger ribonucleic acids were expressed in both chronic otitis media with cholesteatoma and chronic otitis media without cholesteatoma.
The levels of expression of endoplasmic reticulum stress messenger ribonucleic acids differed according to clinical features, suggesting that different endoplasmic reticulum stress pathways are involved in the pathophysiology of different types of chronic otitis media.
Cite this article as: Woong Kang D, Jun Kim Y, Soo Kim S, et al.
Comparison of endoplasmic reticulum stress messenger ribonucleic acid expression between chronic otitis media with and without cholesteatoma.
J Int Adv Otol.
2023;19(4):271-276.

Related Results

Functional outcomes of middle ear cholesteatoma surgery
Functional outcomes of middle ear cholesteatoma surgery
Introduction. Chronic otitis media is defined as a persistent inflammation of the middle ear with signs of an infection lasting for three months or longer. Chronic otitis med...
RhoA, ROCK-1, and ROCK-2 Gene Expression and Polymorphisms in Cholesteatoma Patients
RhoA, ROCK-1, and ROCK-2 Gene Expression and Polymorphisms in Cholesteatoma Patients
BACKGROUND: The aim of this study was to evaluate the gene polymorphism and expressions of Rho-A, ROCK-1, and ROCK-2 in cholesteatoma. METHODS: In this study, 120 healthy control g...
Giant Temporal Lobe Cholesteatoma
Giant Temporal Lobe Cholesteatoma
INTRODUCTION: Intracranial cholesteatoma is uncommon about 0.2–1.8% of all tumor lesions, composed of desquamated debris lined by keratinized squamous epithelium, divided into cong...
Expression Patterns of p27Kip1 and Ki‐67 in Cholesteatoma Epithelium
Expression Patterns of p27Kip1 and Ki‐67 in Cholesteatoma Epithelium
AbstractObjectives The cell cycle must be involved in cell proliferation of the epithelium of middle ear cholesteatoma. Cyclins and cyclin‐dependent kinase (CDK) complexes have imp...
Rhinitis-Respect your nose
Rhinitis-Respect your nose
We all know the functions of nose i.e. breathing and smell. The outcome of breathing is to ventilate the lungs and we also know that there is lung compliance which reflects its eff...
Modified classification of infralabyrinthie cholesteatoma and scale of cholesteatoma extention
Modified classification of infralabyrinthie cholesteatoma and scale of cholesteatoma extention
Introduction. Petrous temporal bone (PTB) cholesteatoma is an epidermal cyst, which is the result of uncontrolled growth of keratinizing squamous epithelium in the petrous part of ...
Diagnosis and management of external auditory canal cholesteatoma (EAC)
Diagnosis and management of external auditory canal cholesteatoma (EAC)
Introduction: Cholesteatoma is a lesion formed from keratinized stratified squamous epithelium that occurs in the temporal bone and is often found in the middle ear. Cholesteatoma ...

Back to Top